NEOVASCULARISATION side effect
What is NEOVASCULARISATION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
NEOVASCULARISATION and Recently Reported Side Effects
NEOVASCULARISATION and 15 most Active Side Effect polls
NEOVASCULARISATION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with NEOVASCULARISATION
AVANDAMET CELEBREX DIOVAN FUNGIZONE HUMALOG MAGNEVIST ROFERON XALATANXalatan Side Effects Report #5301309-X
Consumer or non-health professional from FRANCE reported XALATAN problem on Apr 10, 2007. Female patient, 70 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: neovascularisation, retinal oedema, . XALATAN dosage: unknown. During the same period patient was treated with VASTAREL. Patient recovered.
Fungizone Side Effects Report #5513003-0
FUNGIZONE problem was reported by a Health Professional from KOREA, REPUBLIC OF on Nov 05, 2007. Female patient was diagnosed with keratitis fungal and was treated with FUNGIZONE. After drug was administered, patient experienced the following problems/side effects: cataract, neovascularisation, . FUNGIZONE dosage: unknown. Patient recovered.
Celebrex Side Effects Report #5477507-1
Consumer or non-health professional from UNITED STATES reported CELEBREX problem on Sept 25, 2007. Female patient, weighting 130.1 lb, was diagnosed with myofascial pain syndrome, osteoarthritis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: anxiety, neovascularisation, ocular vascular disorder, retinal haemorrhage, retinal vascular thrombosis, visual acuity reduced, . CELEBREX dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Avandamet Side Effects Report #5377436-8
AVANDAMET problem was reported by a Consumer or non-health professional from FINLAND on June 27, 2007. Female patient, 71 years of age, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: cardiac failure, neovascularisation, swelling, . AVANDAMET dosage: unknown. During the same period patient was treated with AMARYL, BISOPROLOL. Patient was hospitalized. Patient recovered.
Avandamet Side Effects Report #5377436-8
Consumer or non-health professional from FINLAND reported AVANDAMET problem on June 27, 2007. Female patient, 71 years of age, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: cardiac failure, neovascularisation, swelling, . AVANDAMET dosage: unknown. During the same period patient was treated with AMARYL, BISOPROLOL. Patient was hospitalized. Patient recovered.
Magnevist Side Effects Report #5347434-9
MAGNEVIST problem was reported by a Physician from UNITED STATES on June 04, 2007. Female patient, weighting 303.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, scan with contrast and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: hyperkeratosis, neovascularisation, nephrogenic fibrosing dermopathy, skin fibrosis, skin lesion, skin nodule, . MAGNEVIST dosage: unknown. Patient recovered.
Diovan Side Effects Report #5632941-1
Physician from UNITED KINGDOM reported DIOVAN problem on Feb 06, 2008. Male patient, 57 years of age, was diagnosed with renal disorder and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: aneurysm, migraine, neovascularisation, visual acuity reduced, visual disturbance, vitreous floaters, . DIOVAN dosage: 160 MG, QD. Patient recovered.
Roferon Side Effects Report #5792984-4
ROFERON problem was reported by a Physician from UNITED STATES on June 16, 2008. Male patient, 87 years of age, was treated with ROFERON. After drug was administered, patient experienced the following problems/side effects: eye injury, neovascularisation, visual disturbance, . ROFERON dosage: 9 MILLION IU, 0.5 ML.. During the same period patient was treated with AVASTIN, LUCENTIS. Patient recovered.
Humalog Side Effects Report #5381025-9
Consumer or non-health professional from UNITED STATES reported HUMALOG problem on Nov 16, 2006. Male patient, 40 years of age, was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: diabetic retinopathy, neovascularisation, . HUMALOG dosage: unknown. During the same period patient was treated with HUMULIN N, HUMULIN R, ILETIN, HUMALGO PEN. Patient recovered.